Bluebird Bio
Bluebird Bio
Roche’s $50B US Boost: Jobs and Growth Ahead!
BIOT
Roche is investing $50B in U.S. manufacturing and R&D, creating jobs and addressing looming tariffs! 🇺🇸🏭📈 Biopharma Investment
Bluebird Bio’s $150M Funding Revolutionizes Gene Therapy
BIOT
💰 Bluebird Bio seeks $150m funding to support 💉 gene therapy launch. Exciting potential to transform treatment of genetic diseases! 🌍🚀🔬💸
